Register a trial

Please note that the ANZCTR website will be unavailable from 1pm until 2pm (AEST) on Thursday 15th May for website maintenance. Please be sure to log out of the system in order to avoid any loss of data. Thank you and apologies for any inconvenience caused.

Reset your password and enable multi-factor authentication (MFA)


For ANZCTR account holders: to help ensure the cyber safety of your account, you’ll need to reset your password and set-up multi-factor authentication (MFA) as per the instructions below.


  1. Go to the Login page, click ‘reset password’ and follow the instructions.
  2. Check your email for the link to set a new password.
  3. Create a new password that meets requirements. New passwords must include at least one lowercase letter, one uppercase letter, one number and one special character (e.g. !#$%&@).
  4. Return to the Login page and enter your new password. A verification code will be sent to your email.
  5. Check your email for the code and enter it on the Login page. If the code is entered incorrectly, you can re-enter the correct one or request a new one.

Learn more about MFA and its importance on the Australian Signals Directorate website.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT05934422




Registration number
NCT05934422
Ethics application status
Date submitted
4/05/2023
Date registered
7/07/2023

Titles & IDs
Public title
NiPPeR Randomised Trial - Child Follow Up Study
Scientific title
Nutritional Intervention Preconception and During Pregnancy to Maintain Healthy Glucose Metabolism and Offspring Health - Child Health and Well-being Follow Up Study
Secondary ID [1] 0 0
79093
Universal Trial Number (UTN)
Trial acronym
NiPPeR Child
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Obesity, Childhood 0 0
Cognition 0 0
Neurobehavioral Manifestations 0 0
Metabolic Disturbance 0 0
Growth Disorders 0 0
Allergy 0 0
Atopic Dermatitis 0 0
Atopy 0 0
Nutrition, Healthy 0 0
Lifestyle 0 0
Microbial Colonization 0 0
Breastfeeding 0 0
Condition category
Condition code
Infection 0 0 0 0
Studies of infection and infectious agents
Infection 0 0 0 0
Other infectious diseases
Infection 0 0 0 0
Sexually transmitted infections
Neurological 0 0 0 0
Other neurological disorders
Skin 0 0 0 0
Dermatological conditions
Skin 0 0 0 0
Other skin conditions
Diet and Nutrition 0 0 0 0
Obesity
Musculoskeletal 0 0 0 0
Other muscular and skeletal disorders
Metabolic and Endocrine 0 0 0 0
Other endocrine disorders
Human Genetics and Inherited Disorders 0 0 0 0
Other human genetics and inherited disorders

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Other interventions - Intervention (Study Nutritional Drink)
Other interventions - Control (Standard Nutritional Drink)

Experimental: Prior Intervention - enhanced micronutrients, probiotics, myo-inositol in preconception & pregnancy - NiPPeR Study intervention drink containing a mix of micronutrients, probiotics and myo-inositol given to the mother during preconception \& pregnancy

Active comparator: Prior Control - standard micronutrients in preconception & pregnancy - NiPPeR Study control nutritional drink containing a mix of micronutrients given to the mother during preconception \& pregnancy


Other interventions: Intervention (Study Nutritional Drink)
Study nutritional drink containing a mix of enriched micronutrients, probiotics and myo-inositol.

Other interventions: Control (Standard Nutritional Drink)
Control nutritional drink containing a standard mix of micronutrients
Intervention code [1] 0 0
Other interventions
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Child Body Mass Index (kg/m2), derived from weight and height
Assessment method [1] 0 0
Child size and body composition
Timepoint [1] 0 0
Up to age 8 years, from periconception to age 8 years
Primary outcome [2] 0 0
Intellectual function (WASI-II IQ [4 sub-test scores], higher score is a higher IQ)
Assessment method [2] 0 0
Child cognition
Timepoint [2] 0 0
Up to age 8 years, from periconception to age 8 years
Primary outcome [3] 0 0
Child insulin resistance (HOMA2-IR [no units], higher value is greater insulin resistance)
Assessment method [3] 0 0
Child insulin resistance
Timepoint [3] 0 0
Up to age 8 years, from periconception to age 8 years
Primary outcome [4] 0 0
Dimensional Change Card Sort Test (raw & T-scores)
Assessment method [4] 0 0
Child executive functioning - NIH Toolbox Cognition Battery component
Timepoint [4] 0 0
Up to age 8 years, from periconception to age 8 years
Primary outcome [5] 0 0
Flanker Inhibitory Control & Attention Test (raw & T-scores)
Assessment method [5] 0 0
Child executive functioning - NIH Toolbox Cognition Battery Component
Timepoint [5] 0 0
Up to age 8 years, from periconception to age 8 years
Primary outcome [6] 0 0
Strengths & Difficulties Questionnaire score (no units)
Assessment method [6] 0 0
Child neurobehavioural functioning
Timepoint [6] 0 0
Up to age 8 years, from periconception to age 8 years
Primary outcome [7] 0 0
Child Behaviour Check List score (no units)
Assessment method [7] 0 0
Child neurobehavioural functioning
Timepoint [7] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [1] 0 0
Body fat mass (kg, % and indices)
Assessment method [1] 0 0
Obesity and body composition
Timepoint [1] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [2] 0 0
Change in body fat mass (kg)
Assessment method [2] 0 0
Adiposity gain
Timepoint [2] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [3] 0 0
Body lean mass (kg, % and indices)
Assessment method [3] 0 0
Child body composition - lean mass
Timepoint [3] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [4] 0 0
Change in lean mass (kg)
Assessment method [4] 0 0
Lean mass gain
Timepoint [4] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [5] 0 0
Body bone mass (kg, % and indices)
Assessment method [5] 0 0
Child body composition - bone mass
Timepoint [5] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [6] 0 0
Change in bone mass (kg)
Assessment method [6] 0 0
Bone mass gain
Timepoint [6] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [7] 0 0
Child height (cm)
Assessment method [7] 0 0
Child height
Timepoint [7] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [8] 0 0
Height growth (cm)
Assessment method [8] 0 0
Linear growth
Timepoint [8] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [9] 0 0
Change in body mass index (z-score & percentile)
Assessment method [9] 0 0
Change in BMI
Timepoint [9] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [10] 0 0
Change in weight (kg)
Assessment method [10] 0 0
Weight gain
Timepoint [10] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [11] 0 0
Child mid-upper arm circumference (cm)
Assessment method [11] 0 0
Child arm circumference
Timepoint [11] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [12] 0 0
Change in mid-upper circumference (z-score)
Assessment method [12] 0 0
Change in soft tissue mass
Timepoint [12] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [13] 0 0
Child waist circumference (cm)
Assessment method [13] 0 0
Child waist circumference
Timepoint [13] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [14] 0 0
Change in waist circumference (z-score)
Assessment method [14] 0 0
Adiposity gain
Timepoint [14] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [15] 0 0
Heart rate response to step test (beats per minute)
Assessment method [15] 0 0
Cardiovascular fitness and function
Timepoint [15] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [16] 0 0
Child blood pressure (mm Hg)
Assessment method [16] 0 0
Cardiovascular fitness and function
Timepoint [16] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [17] 0 0
Child resting heart rate (beats per minute)
Assessment method [17] 0 0
Cardiovascular fitness and function
Timepoint [17] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [18] 0 0
Child minutes to return to resting heart rate (minutes)
Assessment method [18] 0 0
Cardiovascular fitness and function
Timepoint [18] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [19] 0 0
Diagnosed medical conditions or disorders ascertained by questionnaire, including child medical conditions, infections, gastrointestinal, cardiovascular, respiratory, dermatological, neuropsychological, mental and musculoskeletal health and wellbeing
Assessment method [19] 0 0
Child health and wellbeing
Timepoint [19] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [20] 0 0
Dietary patterns ascertained by frequency questionnaires
Assessment method [20] 0 0
Child diet
Timepoint [20] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [21] 0 0
Child Eating Behaviour Questionnaire
Assessment method [21] 0 0
Child eating behaviours
Timepoint [21] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [22] 0 0
Parental Feeding Practices Questionnaire
Assessment method [22] 0 0
Parental feeding practices
Timepoint [22] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [23] 0 0
Children's Sleep Habits Questionnaire
Assessment method [23] 0 0
Child sleep patterns
Timepoint [23] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [24] 0 0
Children's actigraphy measurements of activity behaviours [minutes/day]
Assessment method [24] 0 0
Child physical activity, sleep and sedentary behaviours
Timepoint [24] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [25] 0 0
Child Movement Behaviour Questionnaire
Assessment method [25] 0 0
Child activity behaviours
Timepoint [25] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [26] 0 0
Skin pricks test results to allergens [mm]
Assessment method [26] 0 0
Child atopic sensitisation
Timepoint [26] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [27] 0 0
Child asthma, wheezing illnesses, eczema, rhinitis and food allergy by clinical examination & questionnaires
Assessment method [27] 0 0
Child atopic and allergic wellbeing and disorders
Timepoint [27] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [28] 0 0
Hair metabolome panel concentrations (pmol/L)
Assessment method [28] 0 0
Biomarkers of health and wellbeing measured in hair samples
Timepoint [28] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [29] 0 0
Urine micronutrient concentrations (nmol/L)
Assessment method [29] 0 0
Child micronutrient status
Timepoint [29] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [30] 0 0
Blood micronutrient concentrations (nmol/L)
Assessment method [30] 0 0
Child circulating micronutrient profile
Timepoint [30] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [31] 0 0
Blood trace element concentrations (pmol/L)
Assessment method [31] 0 0
Child circulating trace element profile
Timepoint [31] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [32] 0 0
Urine trace element concentrations (pmol/L)
Assessment method [32] 0 0
Child trace element status
Timepoint [32] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [33] 0 0
Stool metagenomic profile (abundance)
Assessment method [33] 0 0
Child gut microbiota composition
Timepoint [33] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [34] 0 0
Skin metagenomic profile (abundance)
Assessment method [34] 0 0
Child skin microbiota composition
Timepoint [34] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [35] 0 0
Stool metatranscriptomic profile (relative activity)
Assessment method [35] 0 0
Child gut microbiota activity profile
Timepoint [35] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [36] 0 0
Skin metatranscriptomic profile (relative activity)
Assessment method [36] 0 0
Child skin microbiota activity profile
Timepoint [36] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [37] 0 0
Stool metabolomic profile (pmol/L)
Assessment method [37] 0 0
Child gut microbiota metabolite profile
Timepoint [37] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [38] 0 0
Skin metabolomic profile (pmol/L)
Assessment method [38] 0 0
Child skin microbiota metabolite profile
Timepoint [38] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [39] 0 0
Blood molecular profile (% methylation)
Assessment method [39] 0 0
Child blood epigenetic profile
Timepoint [39] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [40] 0 0
Buccal molecular profile (% methylation)
Assessment method [40] 0 0
Child buccal cell epigenetic profile
Timepoint [40] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [41] 0 0
Blood transcriptomic profile (relative expression)
Assessment method [41] 0 0
Child blood transcriptomic profile
Timepoint [41] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [42] 0 0
Buccal transcriptomic profile (relative expression)
Assessment method [42] 0 0
Child buccal cell transcriptomic profile
Timepoint [42] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [43] 0 0
Genetic variation (DNA sequence analysis)
Assessment method [43] 0 0
Genetic variant analysis
Timepoint [43] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [44] 0 0
Circulating chemocytokine measurements (nmol/L)
Assessment method [44] 0 0
Child chemocytokine profile
Timepoint [44] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [45] 0 0
Circulating adipokine measurements (nmol/L)
Assessment method [45] 0 0
Child adipokine profile
Timepoint [45] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [46] 0 0
Circulating inflammatory marker measurement (nmol/L)
Assessment method [46] 0 0
Child inflammatory factor profile
Timepoint [46] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [47] 0 0
Plasma glucose concentration (mmol/L)
Assessment method [47] 0 0
Child's plasma glycemia
Timepoint [47] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [48] 0 0
Plasma lipid concentrations (mmol/L)
Assessment method [48] 0 0
Child's metabolic profile - lipid concentrations
Timepoint [48] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [49] 0 0
Plasma high-sensitivity C-reactive protein concentrations (mmol/L)
Assessment method [49] 0 0
Child's inflammatory marker status
Timepoint [49] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [50] 0 0
Blood metabolome panel concentrations (pmol/L)
Assessment method [50] 0 0
Child's blood metabolomic status
Timepoint [50] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [51] 0 0
Urine metabolome panel concentrations (pmol/L)
Assessment method [51] 0 0
Child's urine metabolomic status
Timepoint [51] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [52] 0 0
Urine measurement of environmental pollutant exposure (pmol/L)
Assessment method [52] 0 0
Urine exposome pollutant profile
Timepoint [52] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [53] 0 0
Blood measurement of environmental pollutant exposure (ng/gm lipid)
Assessment method [53] 0 0
Blood exposome pollutant profile
Timepoint [53] 0 0
Up to age 8 years, from periconception to age 8 years
Secondary outcome [54] 0 0
Hair measurement of environmental pollutant exposure (pmol/L)
Assessment method [54] 0 0
Hair exposome pollutant profile
Timepoint [54] 0 0
Up to age 8 years, from periconception to age 8 years

Eligibility
Key inclusion criteria
All children still participating in the NiPPeR study at 6-8 years.
Minimum age
6 Years
Maximum age
8 Years
Sex
Both males and females
Can healthy volunteers participate?
Yes
Key exclusion criteria
Known significant congenital anomaly or genetic condition that influences child growth or neurodevelopment.

Study design
Purpose of the study
Prevention
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s
The people administering the treatment/s
The people assessing the outcomes
The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Not applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Recruiting
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
16/06/2023
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
30/08/2025
Actual
Sample size
Target
510
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
Recruitment outside Australia
Country [1] 0 0
New Zealand
State/province [1] 0 0
Auckland
Country [2] 0 0
Singapore
State/province [2] 0 0
Singapore
Country [3] 0 0
United Kingdom
State/province [3] 0 0
Hampshire

Funding & Sponsors
Primary sponsor type
Other
Name
University of Southampton
Country
Other collaborator category [1] 0 0
Other
Name [1] 0 0
National University Hospital, Singapore
Country [1] 0 0
Other collaborator category [2] 0 0
Commercial sector/industry
Name [2] 0 0
Auckland UniServices Ltd.
Country [2] 0 0
Other collaborator category [3] 0 0
Other
Name [3] 0 0
Institute for Human Development and Potential (IHDP), Singapore
Country [3] 0 0
Other collaborator category [4] 0 0
Other
Name [4] 0 0
National University of Singapore
Country [4] 0 0
Other collaborator category [5] 0 0
Other
Name [5] 0 0
National University Health System, Singapore
Country [5] 0 0
Other collaborator category [6] 0 0
Other
Name [6] 0 0
University of Auckland, New Zealand
Country [6] 0 0

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Wayne S Cutfield, MB MD FRACP
Address 0 0
The University of Auckland
Country 0 0
Phone 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Email 0 0
Contact person for scientific queries

Data sharing statement


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

No documents have been uploaded by study researchers.


Results not provided in https://clinicaltrials.gov/study/NCT05934422